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Abstract: - Adequate zinc is critical for immune function. HIV infection progressively destroys the immune system and increase 
the susceptibility to opportunistic infection. Some scientific papers have linked zinc deficiency with decrease CD4 lymphocyte. We 
conducted a meta-analysis to evaluate the efficacy of zinc supplementation for prevention of immunologic failure among HIV adults. 
The review was conducted and reported according to the Preferred Reporting Items for systematic Reviews and Meta-analysis 
(PRISMA). Eligible studies regardless of their publication status were identified by searching electronic literature using PUBMED 
and Cochrane. We included all RCT comparing orally administered zinc with placebo. Assessment for study inclusion, data 
extraction and risk of bias analyses were performed in duplicate. 
We included 7 trials involving 1,611 participants. Result showed a significant p value of 0.003. Out of 873 adult patients included 
in the study that was on zinc supplementation (experimental group), a total of 424 (48.57%) patients had progression of immunologic 
failure. On the other hand, out of 758 adult patients, a total of 418 (55.14%) patients that had immunologic failure on the controlled 
group. This showed a significant result with a p value of 0.003 and a C.I of 0.74 (0.61-0.90). 
The results of our meta-analysis showed that oral zinc supplementation may prevent progression of immunologic failure among HIV 
infected adults. However, large high quality trials are needed before definitive recommendations for clinical practice can be made. 
Adverse effects were common and should be the point of future study, because a good safety and tolerance profile is essential to any 
supplement. 
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I. INTRODUCTION 
Since its first discovery in an Iranian male in 1961, zinc 
deficiency in human is now known to be an important 
malnutrition problem worldwide (1). Zinc is an essential 
micronutrient for human metabolism that catalyzes more than 
100 enzymes, facilitates protein folding and help regulate gene 
expression (2). Zinc supplementation may be effective for the 
prevention of URTI and diarrhea. Human IV infection are 





HIV is a virus that spread through certain body fluids that 
attacks the body’s immune system.  
Overtime, HIV can destroy so many of cells such as CD4 cells 
that the body can’t fight off infections and disease (3). 
Baum et.al, recently reported a benefit of zinc supplementation 
without adverse effect to prevent immunological failure in HIV 
patient.  
Literature has postulated that HIV activation is associated with 
long-term oxidative stress.  
Scientific papers have linked zinc deficiency with decrease 
CD4 lymphocytes and decrease survival. Baum et al showed in 
2010 and in 2013, that supplementation with anti-oxidant, 
vitamins and minerals was associated with longer survival and 
fewer immunological failure. 
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II. PATIENTS AND METHODS 
A. Search Strategy 
The review was conducted and reported according to the 
Preferred Reporting Items for systematic Reviews and Meta-
analysis (PRISMA). Eligible studies regardless of their 
publication status were identified by searching electronic 
literature using PUBMED and Cochrane. All randomized 
controlled trials involving the use of zinc supplementation to 
prevent progression to immunologic failure are published in 
English Language. The search was done by Keywords: HIV, 
Zinc supplementation, Immunologic failure and in 
combination. The electronically generated list of eligible 
studies for inclusion were hand searched to avoid missing any 
relevant studies. 
B. Inclusion And Exclusion Criteria 
Studies were selected for this metanalysis if they met the 
following inclusion criteria: 1. the study is a Randomized 
controlled clinical trial design, reported as full text and 
published in the English language. 2. Participants in the study 
include adults (over 18 years old) including those who 
diagnosed with HIV with ART or without ART treatment. 3. 
Adult patient >18 years old with confined HIV infection based 
on Western blotting test result. They were all reported to have 
CD4> 200 mm3. 
The exclusion criteria were pregnancy, history of 
Hypersensitivity to zinc, uncontrolled virus >40 copies per ml, 
patient who previously received zinc supplementation. 
III. DATA EXTRACTION AND VALIDITY ASSESSMENT 
The literature search, data extraction, and quality assessment 
were independently undertaken by two authors (AMQ and AC) 
using a standardized approach. Any inconsistencies were 
settled by arbitration with the primary author (AMQ) until a 
consensus was reached. Assessment of validity of the included 
studies were performed using the quality scale for metanalytic 
reviews provided by our recent training (SLMC) by the two 
mentioned investigators. The risk of bias tool encompasses 8 
domains which included allocation concealment, physician 
caring for the patient blinded regarding the treatment, intention 
to treat analysis conducted and person making an outcome 
assessment blinded regarding treatment, groups being 
compared balanced in terms of known determinants outcome, 
groups treated equally in terms of other medication received, 
frequency of follow up and general quality of care, dropout 
rates between the groups comparable and outcome detection 
methods used in similar in both groups.  
A checklist was generated (Appendices) and studies were given 
an assessment of “yes”, “no”, or “NS”. Table 1.2 shows a 
summary of the risk of bias. Most studies were rated as having 
low risk of bias. 
 
Fig.1. Flow chart of study selection 
IV. STUDY SELECTIONS 
We identified more than 1,530 articles during our initial 
electronic search, of which 1340 were excluded following an 
initial review (title and abstract). We retrieved the full text for 
the remaining 190 articles, and 7 randomized controlled trials 
were found to meet all of the inclusion criteria in which the 
investigators involved a total of 1,631 randomized patients who 
underwent zinc supplementation of more than 6 months. 
(Figure 1.1) 
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V. STATISTICAL ANALYSIS 
Statistical analysis was performed using Review Manager 
(RevMan) Version 5.3 freeware program developed by the 
Cochrane Collaboration. For this meta-analysis, we allocated 
the results of each randomized controlled trial as dichotomous 
frequency data. The relative risks (RRs) and 95% confidence 
intervals (CIs) of the individual trials were calculated from the 
event numbers extracted from each trial before data pooling. 
The homogeneity among studies were examined using chi 
square test. A Forrest plot was generated by combining the OR 
of included studies using a random effects model. 
VI. RESULTS 
Result showed a significant p value of 0.003. Out of 873 adult 
patients included in the study that was on zinc supplementation 
(experimental group), a total of 424 (48.8%) patients had 
progression of immunologic failure. On the other hand, out of 
758 adult patients, a total of 418 (48.9) patients that had 
immunologic failure on the controlled group. This showed a 




Several studies have shown that zinc supplementation has 
significantly prevent the progression of immunologic failure 
among HIV infected adults by preventing the decline of CD4 
count. This constitutes the therapeutic dilemma and has 
prompted investigator to investigate if Zinc supplementation 
can specifically be used in preventing the progression of 
immunologic failure among HIV infected adult. 
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In 2010 Baum et al, investigated their participants who had low 
plasma zinc levels. HIV viral load, complete blood counts and 
blood chemistry including parameters of renal and liver 
function were monitored at baseline and every 6 months and 18 
months. This study demonstrated that long term zinc 
supplementation delayed immunological failure and decreased 
diarrhea over time. After 3 years, another study was published; 
Asdamongkol et al where plasma zinc levels were measured 
after 6 months of zinc supplementation. In this study, they 
concluded that the CD4+ cell count significantly increased after 
zinc supplementation in patients with low plasma zinc levels. 
On the same year, another study conducted on Mendellin 
Columbia, they were able to select an HIV confirmed 
participants and evaluated after 12 weeks. They concluded that 
patients who receive zinc sulfate supplement could increase the 
CD4 lymphocyte significantly. In the study of Green et al., 
Gnatienko et al., Carcamo et al., and Hadadi et al, these study 
conluded a negative result, that supplemental zinc had no 
significant effect on the duration or remission of immunologic 
failure among HIV infected adults. Possible explanations were 
postulated during analysis of these different conclusions. One 
possible explanation is that the schedule of follow up and 
reassessment are different in each study. The longer the 
supplementation such as in study of Baum et al, the more 
positive outcome. 
In this meta-analysis, we found out that zinc supplementation 
have significant effect on preventing immunologic failure 
among HIV infected adults. 
VIII. CONCLUSION 
In conclusions, there is currently sufficient evidence to 
advocate the use of zinc supplementation to prevent 
immunologic failure among HIV infected adults. In the 
presence of significant evidence in this study, Zinc 
supplementation can be recommended as a supplement to 
prevent immunologic failure. 
IX. RECOMMENDATIONS 
A more precise and descriptive, clinical trials may be needed to 
determine the true effect of zinc supplementation among HIV 
infected adults. Future randomized clinical trials with 
supplementation for a longer period while assessing the viral 
load can help better evaluate the potential benefits of zinc 
supplementation among HIV infected adults. Adverse effects 
were common and should be the point of future study, because 
a good safety and tolerance profile is essential to any 
supplement. 
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